Nektar Therapeutics | NKTR - Pre Utilidad Fiscal





Pre Utilidad Fiscal Cambio Fecha
Agios Pharmaceuticals USD -99.11M 9.94M 2026-03
ALKERMES USD -61.93M 122.3M 2026-03
Alterity Therapeutics Limited AUD -4.74M 3.53M 2024-12
Amgen USD 1.51B 2.41B 2025-12
Baxter International USD -756M 877M 2025-12
BioCryst Pharmaceuticals USD 248.02M 235.89M 2025-12
Biogen USD 377.7M 433.7M 2026-03
Bristol-Myers Squibb USD 1.47B 1.64B 2025-12
Cara Therapeutics USD -4.91M 3.17M 2025-03
Cipla INR 7.49B 4.2B 2026-03
Dr.Reddys Laboratories INR 4.58B 11.09B 2026-03
Eisai JPY -7.94B 29.94B 2026-03
Eli Lilly USD 8.27B 1.03B 2025-12
Esperion Therapeutics USD 63.67M 95M 2025-12
Exelixis USD 267.69M 15M 2026-03
Gilead Sciences USD 2.08B 1.56B 2025-12
GlaxoSmithKline GBP 2.14B 919M 2026-03
Grifols EUR 257.85M 190.87M 2024-12
Halozyme Therapeutics USD 180.33M 281.18M 2026-03
Incyte USD 343.6M 46.34M 2026-03
Ionis Pharmaceuticals USD -93M 135M 2026-03
Ironwood Pharmaceuticals USD 68.02M 30.2M 2025-09
Karyopharm Therapeutics USD -39.9M 9.01M 2025-12
MacroGenics USD -14.93M 31.75M 2025-12
Merck USD 3.42B 3.32B 2025-12
Nektar Therapeutics USD -34.7M 2.35M 2025-12
Neurocrine Biosciences USD 246.8M 7.4M 2026-03
Novartis USD 3.84B 802M 2026-03
Pfizer USD 5.18B 6.82B 2026-03
Roche Holding CHF 4.79B 3.01B 2025-06
Sarepta Therapeutics USD 343.17M 750.85M 2026-03
Takeda JPY -52.48B 186.34B 2026-03
Teva Pharmaceutical Industries USD 753M 662M 2026-03
Xencor USD -128.64M 124.37M 2026-03